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Ethnopharmacological  relevance:  Campomanesia  lineatifolia  Ruiz  and  Pav.  (Myrtaceae)  is  a  native  edible
species  found  in  the  Amazon  Rainforest,  commonly  known  as  gabiroba.  In Brazil,  Campomanesia  species
are  frequently  used  in  traditional  medicine  for gastrointestinal  disorders.
Materials  and  methods:  The  present  study  performed  phytochemical  analyses  and  determined  both  the
in vitro  antioxidant  activity  of  the  ethanolic  extract  of Campomanesia  lineatifolia  leaves  (EEC)  as  well  as  its
ethyl  acetate  fraction  (EAFC).  In  this  analysis,  quercetin  was  used  as  a positive  control.  Gastroprotective
activity  was  also  investigated  at  different  oral  doses  in  two  experimental  models  in  rats  – gastric  lesion
induced  by  ethanol  and  gastric  lesion  induced  by indomethacin.  In  this  analysis,  cimetidine  and  sucralfate
were  used  as positive  controls.  The  area  of gastric  lesion  underwent  macroscopic  and  histomorphometric
evaluations,  while  the  mucus  content  was estimated  by  applying  the  periodic  acid-Schiff  stain.  Oral  acute
toxicity  was  also assessed.
Results:  Phytochemical  studies  revealed  the  presence  of  ﬂavonoids  and  tannins.  Catechin  and  quercitrin
were  isolated  by  bioguided  chromatographic  fractionation  of  EAFC.  EEC  and  EAFC  presented  in vitro
antioxidant  activity.  The  oral  administration  of  EEC  and  EAFC  at  doses  100–400  mg/kg  (ethanol  model)  and
at doses  of  400–1200  mg/kg  (indomethacin  model)  proved  to be  effective  in  preventing  gastric  ulcerations
in  rats.  Pretreatment  with  EAFC  (400  mg/kg)  signiﬁcantly  increased  the  gastric  mucus  content  in  the
ethanol  model.  No  animals  died during  the  acute  oral  toxicology  test.
Conclusions:  Results  conﬁrm  the  Brazilian  ethnopharmacological  use  of Campomanesia  lineatifolia  as  a
gastroprotective  agent  and  indicate  that  the  anti-ulcer  effect  is  most  likely  mediated  by scavenging  free
radicals  due  to the  polyphenol  content  and,  at least  in part,  by increasing  the  mucus  secretion  and  the
mucosal  defense.  In  addition,  EEC  and  EAFC  were  found  to  be safe  when  applied  to  a 2000  mg/kg  single
oral  dose.
© 2011 Elsevier Ireland Ltd. Open access under the Elsevier OA license.. Introduction
Campomanesia lineatifolia Ruiz and Pav. (Myrtaceae), also known
y several common names, such as gabiroba, guavira,  or champa,
s a native edible species found in the Amazon Rainforest in
razil, Colombia, Peru, and Bolivia (D’Eeckenbrugge and Ferla,
000). The fruits of the Campomanesia species are widely used to
ake liqueurs, juices, and sweets (Lorenzi et al., 2006). The leaves
re traditionally employed as a medicine for dysentery, stomach
∗ Corresponding author at: Faculdade de Farmácia – Sala 4138, Universidade Fed-
ral de Minas Gerais, Av. Antônio Carlos, 6.627, Pampulha Belo Horizonte – MG,  CEP:
1270-901, Brazil. Tel.: +55 31 34096891; fax: +55 31 34096985.
E-mail address: carlostagliati@ufmg.br (C.A. Tagliati).
378-8741     © 2011 Elsevier Ireland Ltd.      
oi:10.1016/j.jep.2011.12.014
Open access under the Elsevier OA license.problems, diarrhea (Pio Corrêa, 1952), cistities and uretrites
(D’ávila, 1910), as well as hepatic disorders (Moraes, 1881). They
have also been used to reduce blood cholesterol and induce weight
loss (Dickel et al., 2007).
Souza-Moreira et al. (2011) recently reported on the antidiar-
rheal activity of Campomanesia xanthocarpa. Ktafke et al. (2010)
have demonstrated that Campomanesia xanthocarpa reduced total
cholesterol and LDL levels in the blood of hypercholesterolemic
patients. The same species brought about a signiﬁcant decrease
in blood glucose levels and hepatic glycogen loss and prevented
potential histopathological alterations in the pancreas and kidneys
in streptozotocin diabetic rats (Vinagre et al., 2010). Moreover, the
oral administration of the Campomanesia xanthocarpa extract at
400 mg/kg attenuated gastric mucosal lesions induced by ethanol
in rats (Markman et al., 2004). Antimicrobial activities of hexanic
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xtracts and fractions of Campomanesia pubsenses and Campomane-
ia admantium fruits have also been reported in the literature
Cardoso et al., 2010).
Studies concerning Campomanesia species have commonly
dentiﬁed ﬂavonoids (Schmeda-Hirschmann, 1995; Pavan et al.,
009), monoterpens, and sesquiterpens (Cardoso et al., 2008;
outinho et al., 2009). However, phytochemical investigations of
ampomanesia linetatifolia are rather limited (Bonilla et al., 2005;
sorio et al., 2006), and no speciﬁc studies on in vivo biologi-
al assessments or the safety of this species can be found in the
iterature. The present work describes the antioxidant and gastro-
rotective activities and acute toxicity data of the ethanolic extract
EEC) and respective ethyl acetate fraction (AEFC) of Campomanesia
inetatifolia.  In addition, based on the total tannin and ﬂavonoid con-
ents, as well as the phytochemical analyses of the Campomanesia
ineatifolia extracts and fractions, the present work also analyzes
he compounds that may  well contribute to the gastroprotective
ctivity.
. Material and methods
.1. Plant material
Campomanesia lineatifolia leaves were collected in the state of
inas Gerais, Brazil (19◦52′9.87′′S; 43◦58′12.04′′W).  The species
as identiﬁed by Dr. Marcos Sobral from the Botany Department
f Instituto de Ciências Biológicas at Universidade Federal de Minas
erais (UFMG), Belo Horizonte. A voucher specimen (no. BHCB
50.606) was deposited at the UFMG Herbarium.
.2. Drugs and chemicals
Pyrogallol was obtained from Merck (Brazil); 1,1-diphenyl-2-
icrylhydrazyl, hide powder, quercetin, quercitrin, and catechin
ere purchased from Sigma–Aldrich (Brazil). Indomethacin was
btained from Merck, Sharp & Dohme (Brazil), cimetidine from SKF
Brazil), and sucralfate from Natures Plus Farm Ltda (Brazil). All
ther chemicals used in this study were of analytical grade.
.3. Extraction and isolation
The Campomanesia lineatifolia leaves were dried at 40 ◦C/72 h
ith forced air circulation. The powdered dry leaves (400 g) were
xtracted using ethanol 96% by percolation at room tempera-
ure for 48 h. Evaporation of the solvent under vacuum yielded
4.4 g (23.6%) of dry extract (EEC). The dry EEC (40 g) was
uspended in water (400 mL)  and sequentially partitioned with
our solvents of different polarity, thus yielding four fractions:
exane (2.6 g), CH2Cl2 (2.4 g), EtOAc (5.6 g), and BuOH (10.7 g).
ractionation of EAFC (2.1 g) by High Speed Countercurrent Chro-
atography (HSCCC) was performed using a binary solvent system,
exane:EtOAc:MeOH:H2O (0.6:4.0:0.7:1.0), in which the organic
hase was the mobile phase, in turn producing quercitrin (29.1 mg)
nd catechin (52.6 mg). Isolated compounds were characterized by
pectroscopic techniques, including UV–vis, IR, 1H and 13C NMR,
OSY, DEPT-135, and HSQC. The known ﬂavonoids were identiﬁed
y comparison with reported physical and spectral data (Martinez-
icha and Joseph-Nathan, 2003; Ceruks et al., 2007).
.4. Determination of total ﬂavonoid content
The total ﬂavonoid content was determined using the method
dapted from Brazilian Pharmacopeia IV (Brazilian-Pharmacopeia,
001). Brieﬂy, dry plant material, EEC, and EAFC were hydrolyzed
y reﬂuxing in a boiling acid solution (20 mL  acetone; 1 mL
ethenamine, 0.5% w/v; 7 mL  HCl solution, 25% v/v) for 30 min.armacology 139 (2012) 772– 779 773
After cooling, the ﬂavonoid aglycones were exhaustively extracted
using EtOAc. An aliquot of 10 mL  of EtOAc extracted from each sam-
ple was  added to 1 mL  of AlCl3·6H2O solution (2%, w/v). This mixture
was  combined with 14 mL  of methanolic acetic acid solution (5%,
v/v) and, after 30 min; the absorbances were read at  425 nm. The
blank referred to the same solution without AlCl3·6H2O reagent.
Tests were carried out in triplicate. The total ﬂavonoid content was
calculated from the calibration curve of quercetin standard solu-
tions ranging from 0.4 to 4.8 g/mL. Results were expressed in g of
quercetin per 100 g of sample (%, w/w).
2.5. Determination of tannin content
The quantitative tannin content in samples was estimated using
the method adapted from Brazilian Pharmacopeia IV (Brazilian-
Pharmacopeia, 2002). Brieﬂy, dry plant material, EEC, and EAFC
were diluted in water in known concentrations and boiled for
30 min  under reﬂux and ﬁltrated (sol 1). To 20 mL  of the ﬁltrate,
0.2 g of hide powder was  added and stirred for 1 h (sol 2). A 5 ml
aliquot of both solutions 1 and 2 were diluted in 25 mL  of water.
Finally, an aliquot of 5 mL  of a sample solution was added to 2 mL
of Folin–Denis reagent. This mixture was  combined with 43 mL
of Na2CO3 solution and, after 3 min, the absorbances were read
at  715 nm.  The blank referred to the same solution without
Folin–Denis reagent. Tests were carried out in triplicate. The tan-
nin concentrations were calculated on the basis of the difference
in the optical absorbance values of solutions 1 and 2. The total tan-
nin content was calculated from the calibration curve of pyrogallol
standard solutions ranging from 0.3 to 1.8 g/mL. Results were
expressed in g of pyrogallol per 100 g of sample (% w/w).
2.6. In vitro antioxidant activity – DPPH assay
The free radical scavenging activity of EEC and EAFC was mea-
sured in vitro by means of a 1,1-diphenyl-2-picryl-hydrazyl (DPPH)
spectrophotometric assay (Brandwilliams et al., 1995). One mL  of
an ethanolic DPPH solution (0.3 mM)  was added to 3 ml of extracts
dissolved in ethanol at different concentrations (1.0, 2.5, 5.0, 7.5,
10.0, and 15.0 g/mL). After a 30 min  incubation period at room
temperature, the absorbance level was read by being compared to
a blank solution (without sample) at  516 nm. Sample concen-
tration, providing 50% inhibition (IC50), was calculated using the
linear regression method from the graph, plotting the inhibition
percentage against the sample concentration. The inhibition mode
for all samples was linear. Tests were carried out in triplicate, and
quercetin was  used as a positive control.
2.7. Pharmacology
2.7.1. Animals
Male Wistar rats (200–250 g) were used in this pharmacologi-
cal study. To perform the acute toxicity assay, female Wistar rats
(8–12 weeks) were used according to the OECD 423 (2002) guide-
line methodology. All rats were provided by the Animal Shelter
from the School of Pharmacy at UFMG. The animals were fed a cer-
tiﬁed Nuvilab diet, had free access to tap water, and were left to
adjust to their environment for ﬁve days before applying dosages.
They were kept during all experiments under standard environ-
mental conditions of temperature (25 ± 1 ◦C), humidity (70 ± 10%),
and lighting (12 h light:12 h dark). Protocol was  approved by the
Local Animal Care Committee at UFMG (CETEA no. 52/2010, Brazil),
and all the experimental procedures were carried out in accordance
with international guidelines for the care and use of laboratory
animals.
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Table 1
Groups and treatment doses used in gastroprotective activity assays.
Groups (n = 6) Treatment
CMC  0.5%
(mL/200 g)
EEC (mg/kg) EAFC (mg/kg) Cimetidine
(mg/kg)
Sucralfate
(mg/kg)
Ethanol
(mL/200 g)
Indomethacin
(mg/kg)
Vehicle 2 – – – – – –
Control  A 1 – – – – 1 –
Test  1 – 100 – – – 1 –
Test  2 – – 100 – – 1 –
Test  3 – 200 – – – 1 –
Test  4 – – 200 – – 1 –
Test  5 – 400 – – – 1 –
Test  6 – – 400 – – 1 –
Positive control A1 – – – – 200 1 –
Positive  control A2 – – – 50 – 1 –
Control  B 1 – – – – – 40
Test  7 – 400 – – – – 40
Test  8 – – 400 – – – 40
Test  9 800 – – – – 40
Test  10 – – 800 – – – 40
Test  11 – 1200 – – – – 40
Test  12 – – 1200 – – – 40
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were also digitalized using a scanner (HP scanjet 2400) in 300 dpi
resolution. The total area of histological sections (area of the gas-
tric wall) was determined by selecting pixels in real image using
KS300 (Fahel et al., 2010). The values were expressed as the totalPositive control B1 – – –
Positive control B2 – – – 
.7.2. Evaluation of gastroprotective activity
The rats were fasted for 24 h prior to the experiment in wire
esh cages to avoid coprophagia. The animals had free access to
ater up to 1 h before the experiment. Ethanol- and indometacin-
nduced gastric lesion experiments were performed during the
ame time of day to avoid variations due to diurnal rhythms of
utative regulators of gastric function (Heeba et al., 2009). The rats
ere randomly divided into groups of six animals.
Each group received vehicle carboximetilcelulose (CMC) 0.5%,
EC, EAFC, cimetidine, or sucralfate, orally, through gastric gavage,
 h before the oral administration of the aggressor agents: absolute
thanol 1 mL/200 g b.w. (Robert, 1979) or indomethacin 40 mg/kg
Nagai et al., 2009). After 1 h (ethanol) and after 6 h (indomethacin),
he animals were sacriﬁced, the stomachs were removed, and the
astric contents were collected. The stomachs were washed in ice-
old saline, opened along the great curvature, and ﬁxed in buffered
ormalin (pH 7.2). The groups and the treatment doses are summa-
ized in Table 1.
.7.3. Gastric pH
After having removed the stomach, a small incision was  made
ear the pylorus to collect gastric juices. A pH measurement was
erformed, using tape pH indicators (Merck) (Jorge et al., 2004).
.7.4. Evaluation of macroscopic gastric lesion
After the ﬁxation period, digital photos were taken of the stom-
chs using a Sony® DSC-H50 9.1 megapixel digital camera at a
istance of 5.7 cm from the gastric mucosa, with the zoom feature
ff. The quantitative analysis of gross hemorrhagic spots and bands
hemorrhagic zones) (Arisawa et al., 2006) was performed using the
S300 software from the Carl Zeiss image analyzer (Oberkochen,
ermany). The pixels with shades of black and dark brown, refer-
ing to the hemorrhagic zones, were selected to create a binary
mage, and the area was measured in mm2. Gastroprotection was
alculated as the percentage of decrease of the hemorrhagic zone
rea as compared to that of the control.astroprotection (%) = 1 − [hemorrhagic zones area (mm2)
× of test group/hemorrhagic zone area (mm2)
× of control group (ethanol or indomethacin)]  × 100– 400 – 40
100 – – 40
2.7.5. Microscopic and morphometric analysis of surface areas of
necrosis (erosions) and ulcers
The entire glandular mucosa of each stomach was  divided
into four serial strips parallel to the limiting ridge (Fig. 1). Tis-
sue samples were dehydrated in ethanol series, diaphanized in
xylol, and embedded in parafﬁn. Sections of 5 m in thickness
were stained with periodic acid-Schiff (PAS). The specimens were
analyzed using a 4× objective Axiolab Carl Zeiss light microscope
(Oberkochen, Germany), and all damaged areas, including super-
ﬁcial or deep necrotic erosions and ulcers, were digitalized by
means of a TK-1270/RGB JVC microcamera (Tokyo, Japan) attached
to the microscope. All necrosis areas (m2) of the four histologi-
cal sections were measured using the KS300 software. The slidesFig. 1. Stomach glandular mucosa of indomethacin-treated rat divided into four
serial strips. Arrows indicate the presence of hemorrhagic zones which, under micro-
scopic analysis, correspond to regions of erosion and/or ulcers.
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Table 2
In vitro antioxidant activity of Campomanesia lineatifolia ethanolic extract (EEC),
ethyl acetate fraction (EAFC), cathechin and quercitrin.
In vitro antioxidant activity IC50 (g/mL)
EEC 13.87 ± 0.08**
EAFC 6.83 ± 0.04*
Cathechin 8.20 ± 0.03*
Quercitrin 7.01 ± 0.20*
Quercetin (positive control) 2.34 ± 0.02
Data are expressed as mean ± S.D.; n = 3.
* P < 0.05 when compared to quercetin (one-way ANOVA followed by Tukey’sR.C. Madalosso et al. / Journal of Et
ecrosis area (m2) per 45.3006 mm2 of gastric wall (smallest ana-
yzed gastric wall area).
.7.6. Quantitative analysis of gastric mucus area
The same longitudinal sections were used to calculate the gastric
ucus area. Thirty-two random ﬁelds (8 from each section) were
nalyzed for each stomach, using a 10× objective. PAS+ areas (m2)
ere calculated by selecting pixels of PAS-stained mucosubstances
characteristic carmine colors), given the system’s ability to delin-
ate objects based on their color and intensity. All gastric mucosa
ixels were also selected to calculate the total area of the gas-
ric mucosa (m2). The microscopic imaging methodology, image
egmentation, and morphometric conditions were performed as
escribed by Caliari (1997).  The Mucus Index (M.I.) was  calculated
y determining the ratio of the PAS+ area to the area of gastric
ucosa. This index was analyzed as an indicator of the amount of
astric mucus.
.8. Acute toxicity studies
Rats were fasted for one night prior to the administration of
he drug. A total of six animals were used, which received either
 vehicle (CMC 0.5%) or a single oral dose (2000 mg/kg, b.w.) of
ampomanesia lineatifolia leaf extract (EEC or EAFC). After the
dministration of the drug, food was withheld for another 3–4 h.
nimals were observed individually at least once in the ﬁrst 30 min
fter dosing, periodically during the ﬁrst 24 h (with special atten-
ion paid during the ﬁrst 4 h), and daily thereafter for a period of
4 days. Daily cage-side observations included changes in skin and
ur, in eyes and mucous membrane (nasal), as well as respiratory
ate, heart rate, autonomic (salivation, lacrimation, perspiration,
iloerection, urination, and defecation), and central nervous sys-
em (ptosis, drowsiness, gait, tremors, and convulsion) changes.
ndividual animal weights were determined shortly before the
dministration of doses and weekly thereafter. Food and water con-
umption were also evaluated. Mortality, if any, was  determined
ver a 2-week period. At the end of the test, all animals were
ubjected to gross necropsy, and all pathological changes were
ecorded (OECD, 2002).
.9. Statistical analysis
For phytochemical and in vitro antioxidant activity analyses,
ata were expressed as mean ± S.D., and as mean ± S.E.M. for
n vivo evaluations (toxicology and gastroprotective activity). A
alue of P < 0.05 was considered statistically signiﬁcant. Statisti-
al evaluation was performed by one-way analyses of variance
ANOVA) followed by Tukey (phytochemical and antioxidant) or
ewman–keus (in vivo determinations) tests for multiple com-
arisons. All analyses were performed using the GraphPrism5
tatistical software.
. Results
.1. Phytochemical analysis and in vitro antioxidant activity
Phytochemical assays revealed the presence of ﬂavonoids and
annins in the Campomanesia lineatifolia leaves, EEC and EAFC.
he bioguided chromatographic fractionation of EAFC yielded the
solation of (+)-catechin (2R,3S)-5,7,3′,4′-tetra-hidroxilﬂavan-3-ol
catechin) and quercetin 3-O--ramnoside (quercitrin). The high-
st ﬂavonoid content was observed in EAFC (9.3 ± 0.3%) (P < 0.05).
he ﬂavonoid content found in EEC and the dry plant material were
.0 ± 0.1% and 1.0 ± 0.1%, respectively. The highest tannin content
as observed in EEC (18.7 ± 0.1%) (P < 0.05). The tannin contenttest).
** P < 0.01 when compared to quercetin (one-way ANOVA followed by Tukey’s
test).
found in EAFC and the dry plant material were 16.5 ± 0.3% and
3.1 ± 0.1%, respectively.
EEC, EAFC and the two isolated compounds reduced DPPH to a
yellow colored product in a concentration dependent manner. The
IC50 values are shown in Table 2. Since the EAFC fraction presented
a greater antioxidant activity than did the Hex, CH2Cl2, and BuOH
fractions (data not shown), this fraction was chosen, along with
EEC, to be used in the gastroprotective activity and acute toxicity
studies.
3.2. Gastric pH
In the absolute ethanol-induced gastric lesion model, as com-
pared to the vehicle group, no signiﬁcant differences in the gastric
pH of the groups treated with sucralfate, EEC, and EAFC could be
observed at any of the tested doses (pH = 3.1 ± 1.0). In this model,
only cimetidine (pH = 7.7 ± 0.2) induced an increase in pH (P < 0.05).
However, in the indomethacin-induced gastric lesion model, the
gastric pH proved to be higher than that of the vehicle group in
animals treated with cimetidine (pH = 4.9 ± 0.5), EAFC 800 mg/kg
(pH = 4.5 ± 0.2), and EAFC 1200 mg/kg (pH = 4.5 ± 0.2) (P < 0.05).
3.3. Macroscopic gastric lesion evaluation (hemorrhagic zones)
Intragastric administration of ethanol led to the development
of hemorrhagic bands in the glandular portion of the rats’ gastric
mucosa. The control group presented a mean hemorrhagic zone
area of 90.7 ± 8.6 mm2. The treatment of the rats with EEC and EAFC
(100–400 mg/kg) brought about a signiﬁcant (P < 0.05) decrease in
the gastric hemorrhagic zones in a dose dependent manner (EEC,
r2 = 0.75; FAEC, r2 = 0.79). The hemorrhagic zone areas (mm2) are
presented in Fig. 2 (upper graph). At the macroscopic level, EEC at
doses of 100, 200, and 400 mg/kg demonstrated 68.8%, 93.7%, and
99.6% gastroprotection. Gastroprotection induced by EAFC at the
same doses were 90.9%, 94.7%, and 99.9%, respectively. The positive
control sucralfate (200 mg/kg) group provided a 98.6% gastropro-
tection. However, the cimetidine (50 mg/kg) exerted no effective
gastroprotection (47.7%) in this model.
The intragastric administration of indomethacin at 40 mg/kg
induced a gastric injury that could be viewed macroscopically as
hemorrhagic spots in the glandular portion of the rats’ gastric
mucosa. The control group presented a mean hemorrhagic zone
area of 11.78 ± 1.14 mm2. As EEC at a dose of 200 mg/kg produced
no signiﬁcant effect in this model (10.92 ± 0.99 mm2) (P > 0.05), the
tests were therefore performed using higher EEC, EAFC, and, posi-
tive control doses. The treatment of the rats with EEC and EAFC at
doses of 400–1200 mg/kg triggered a signiﬁcant (P < 0.05) decrease
in the gastric hemorrhagic zones in the rats’ gastric mucosa in a
dose dependent manner (EEC, r2 = 0.78; EAFC, r2 = 0.72). The hem-
orrhagic zone areas (mm2) are presented in Fig. 3 (upper graph).
At the macroscopic level, EEC at doses of 400, 800, and 1200 mg/kg
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Fig. 2. Graph of hemorrhagic zone areas (mm2) (upper) and necrosis areas (m2)
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Fig. 3. Graph of hemorrhagic zone areas (mm2) (upper) and necrosis areas (m2)lower). Ethanol-induced gastric lesion model. Doses: 100, 200, or 400 mg/kg of EEC
r  EAFC; suc.: sucralfate 200 mg/kg; cim.: cimetidine 50 mg/kg. Distinct letters (a,b,c)
iffer signiﬁcantly. Newman–Keus (P < 0.05).
emonstrated 67.0%, 89.2%, and 98.8% gastroprotection. The gastro-
rotection induced by EAFC at the same doses were 32.3%, 74.7%,
nd 98.1%, respectively. The positive control sucralfate (400 mg/kg)
nd cimetidine (100 mg/kg) groups provided 81.2% and 95.0% gas-
roprotection, respectively.
.4. Microscopic gastric lesion evaluation (necrosis)
The microscopic appearance of necrosis regions in absolute
thanol treated rats revealed damaged areas down to deep lay-
rs of the mucosa. In the indomethacin model, the histopathologic
nalysis presents necrosis regions, loss of the normal mucosa archi-
ecture and the detachment of tissue, especially in the control
roup. In both models, the treatment of the rats with EEC, and EAFC
aused a signiﬁcant (P < 0.05) decrease in the necrotic area of the
astric mucosa. The necrosis areas (m2) are represented in the
ower graphs of Fig. 2 (ethanol model) and Fig. 3 (indomethacin
odel).
.5. Morphometric analysis of mucus content in gastric mucosa
In the ethanol-induced gastric ulceration model, the EAFC
00 mg/kg treatment led to the development of a substantial con-
inuous PAS stained (PAS-positive) mucous gel layer which covered
he surface of the gastric mucosa. Similar to the vehicle group, a
right, carmine-stained area covering the mucosa and extending
p to the gastric pits could be observed (Fig. 4). Quantitative anal-
sis revealed that EAFC, at a dose of 400 mg/kg, as compared to
ontrol group (0.018 ± 0.005) and groups treated with reference
rugs of sucralfate (0.021 ± 0.004) and cimetidine (0.022 ± 0.007),
roduced a signiﬁcant increase (P < 0.05) in the mucus index (M.I.)
0.104 ± 0.003). Moreover, the M.I. of animals that received EAFC(lower). Indomethacin-induced gastric lesion model. Doses: 400, 800, or 1200 mg/kg
of EEC or EAFC; suc.: sucralfate 400 mg/kg; cim.: cimetidine 100 mg/kg. Distinct
letters (a,b,c,d) differ signiﬁcantly. Newman–Keus (P < 0.05).
at a dose of 400 mg/kg was  similar to that of the vehicle group
(0.122 ± 0.025) (P > 0.05).
Neither EEC, nor EAFC, was able to reestablish the gastric mucus
levels in the indomethacin-induced model. In this model, cimeti-
dine and sucralfate also failed to exert any effect on M.I.
3.6. Acute toxicity studies
A single oral dose of EEC or EAFC (2000 g/kg) produced nei-
ther moderate, nor severe signs of toxicity in the treated animals.
Within the ﬁrst hour after oral administration, a slight reduction
in the locomotory behavior (lethargy) of EAFC-treated rats could
be detected; however, this condition proved to be reversible by the
end of the second hour. After 8 h, the EEC- and EAFC-treated groups
displayed mild constipation, which proved to be reversible within
24 h. No signiﬁcant changes in the consumption of food and water
could be observed in the EEC and EAFC groups, when compared to
the control. After 14 days, no mortality, nor any signiﬁcant changes
in body weight or in the macroscopic aspects of the organs, could
be observed.
4. Discussion
The present study evaluated both the ﬂavonoid and tannin con-
tent as well as the in vitro antioxidant and in vivo gastroprotective
activities of Campomanesia lineatifolia leaf extract and fractions.
EEC and EAFC treatment signiﬁcantly inhibited the development
of gastric lesions induced by the oral administration of ethanol
or indomethacin in rats. In addition, single dose safety could be
deduced from acute oral toxicological tests.
R.C. Madalosso et al. / Journal of Ethnoph
Fig. 4. Histological longitudinal sections of the stomachs (glandular portion) of rats
treated with (a) vehicle; (b) vehicle and ethanol; (c) EAFC 400 mg/kg and ethanol.
N
l
b
t
i
t
c
h
p
n
e
(
h
o
i
b
I
a
z
m
s
d
e
a
dote the presence of small regions stained by PAS (arrow heads) as compared to
arge PAS-stained areas (arrows), indicating different amounts of gastric mucus (PAS,
ars = 40 m).
Prior literature ﬁrmly defends that ﬂavonoids, in addition to
heir antioxidant properties, exhibit multiple biological results,
ncluding anti-inﬂammatory and antibacterial effects. Moreover,
hey are able to inhibit lipid peroxidation and improve increased
apillary permeability (Procházková et al., 2011). Recent studies
ave also reported on anti-ulcer and gastroprotective properties of
lant extracts rich in ﬂavonoids, phenolic acid derivatives, and tan-
ins (Arawwawala et al., 2010; da Silva et al., 2010; Vasconcelos
t al., 2010) that present a high free-radical scavenger potential
Mayer et al., 2009; Eswaran et al., 2010). In the present study, the
igh polyphenolic content in EEC and EAFC suggests that this group
f substances, particularly cathequin and quercitrin, which were
solated and identiﬁed in ethanolic extract and fractions, may  well
e one of the active compounds of Campomanesia lineatifolia leaves.
n addition, the ﬂavonoid content of this study presented a positive
greement with the antioxidant capacity of EEC and EAFC.
The present results show a quantitative decrease in hemorrhagic
ones in both ethanol- and indomethacin-induced gastric lesion
odels. The efﬁcacy of Campomanesia lineatifolia was further sub-
tantiated by quantitative histological ﬁndings, where a marked
ecrease in areas of gastric mucosal necrosis could be observed.Exposure of gastric mucosa to ulcerogenic compounds, like
thanol, has been shown to affect cellular integrity. These changes
re commonly associated with oxidative stress and mitochondrial
amage, due mainly to local effects, coupled with the formation ofarmacology 139 (2012) 772– 779 777
free radicals and reactive oxygen species (ROS) (Repetto and Llesuy,
2002). Furthermore, the administration of ethanol increases lipid
peroxidation, depletes mucus on the gastric surface, and disturbs
microcirculation (Rozza et al., 2011). The present study demon-
strated a more favorable response produced by EAFC, as compared
to EEC, at doses of 100 mg/kg in an ethanol-induced gastric lesion
model. The results suggest that EAFC higher ﬂavonoid content and
higher antioxidant activity did in fact contribute to the scavenging
of the free radicals produced by the metabolism of ethanol, thereby
preventing gastric damage.
Overall, the preventive effects of antisecretory agents on gastric
mucosal injuries caused by ethanol are minimal, whereas those of
gastroprotective drugs proved to be considerable (Arisawa et al.,
2006). Therefore, the good level of gastric protection demonstrated
by oral treatment with EEC and EAFC, as compared to treatments
with cimetidine and sucralfate, in ethanol-induced gastric lesion
models suggests that the extracts do in fact exert a gastroprotective
effect by enhancing the mucosal defense.
In the present study, the administration of EAFC 400 mg/kg sig-
niﬁcantly increases the mucus index (M.I.) in ethanol-treated rats.
Several studies have shown the importance of gastric mucus in gas-
troprotection (Morini et al., 1997; Phillipson et al., 2008; Moraes
et al., 2009). As neutral glycoproteins (PAS+) are the most abun-
dant and possibly the most important glycoprotein in the gastric
mucosa, it can be assumed that a quantitative restitution of M.I.
represents a return to a physiological condition, and thus a recov-
ery of the defensive capacity against aggression (Delalastra et al.,
1994). Therefore, the present results suggest that an increase in the
mucus secretion may  well play a key role in the gastroprotective
mechanisms of Campomanesia lineatifolia.
Treatments with EEC and EAFC signiﬁcantly reduce
indomethacin-induced gastric lesion. Although direct topical
injury may  occur, the major mechanism through which non-
steroidal anti-inﬂammatory drugs (NSAID) cause ulcers and
gastrointestinal complications is thought to be systemic, by
inhibiting the COX-mediated prostaglandin synthesis. However,
other prostaglandin-independent mechanisms are also important
in ulcer pathogenesis (Musumba et al., 2009). The present study’s
results suggest that EEC and EAFC, due to their gastroprotective
effects in the indomethacin model, possess a relevant therapeutic
potential within alternative treatments aimed at reducing NSAID
gastrotoxicity.
The present study demonstrated depleted levels of gastric
mucus in rats with indomethacin-induced gastric lesions, including
those treated with higher doses of EEC and EAFC, as well as with
the reference drugs of cimetidine and sucralfate, despite the gas-
troprotection. Mucus layer is an important target of indomethacin
gastrotoxicity, which is, in part, associated with ROS generation.
The formation of these species occurs in the mucus layer, at
the interface, or in the intracellular compartment of epithelial
cells (Utsumi et al., 2006). Phillipson et al. (2008) reported that
prostaglandins stimulated mucus secretion in rats, resulting in an
increased thickness of the mucus layer, while pretreatment with
indomethacin at a low dose (3 mg/kg) decreased both the mucus
secretion and the thickness of this layer.
In contrast to the ethanol model, the indomethacin model, at
lower evaluated doses, presented a more positive response when
EEC treatment, as compared to EAFC treatment, was applied. This
could be explained, at least in part, by the greater complexity
of EEC as compared to EAFC. Evidence shows that total or par-
tial plant extracts often present a higher level of pharmacologic
activity than do isolated compounds (Wagner et al., 2010). There-
fore, synergism can occur, resulting in a higher activity of EEC
within this model. In addition, the present study’s results show
higher EEC tannin contents, which runs in line with prior literature
that has reported on the gastroprotective activity of plant extracts
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hat are rich in tannins (da Silva et al., 2010; Vasconcelos et al.,
010). These polyphenols are potent scavengers of peroxyl radi-
als that can interact with mucus proteins, in turn improving their
ytoprotective effects by forming a protein lining over the gastroin-
estinal mucosa (Okuda, 2005).
In the indomethacin model, an increase in the gastric pH could
e observed not only in cimetidine, which is an antisecretory agent
Schubert and Peura, 2008), but also in higher doses (800 and
200 mg/kg) of EAFC-treated rats. It has been reported that some
avonoids, including catechin and quercitrin, suppress gastric acid
ecretions primarily by inhibiting gastrin and histamine (Sato et al.,
002; Mota et al., 2009). Furthermore, Ghayur et al. (2007) reported
he antispasmodic and vasodilatator activities of catechin in rat
tomachs, which may  well be important in the maintenance of
ormal mucosal blood ﬂow and gastric integrity. As catechin and
uercitrin were the majority substances in EEC and EAFC, it is possi-
le that these mechanisms could contribute to the pharmacological
asis for the efﬁcacy of Campomanesia lineatifolia extracts in gas-
rointestinal disorders; however, further studies are warranted to
onﬁrm this hypothesis.
The present study was the ﬁrst of its kind to investigate the
cute toxicity of Campomanesia lineatifolia in rats. The absence of
eath and the lack of severe alterations in behavior and clinical
igns indicate the acute oral safety of Campomanesia lineatifolia.
. Conclusion
In conclusion, the results of the present study show that Cam-
omanesia lineatifolia extracts of EEC and EAFC protect the gastric
ucosa against ethanol- and indomethacin-induced gastric lesions.
he gastroprotective effects appear to be related to their antioxi-
ant properties and polyphenolic contents. The present study also
resents a morphometric methodology to quantify the macroscopic
nd microscopic lesions, as well as the area covered by the gastric
ucus, which can be used to evaluate the gastroprotective function
n other studies with similar products.
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